CANCER PAIN AND TREATMENT CHARACTERISTICS in GERMANY – A CROSS_SECTIONAL ONLINE PATIENT SURVEY (CANPAIN)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/31329
• EU PAS number:
  EUPAS31328
• Study ID:
  31329
• Official title and acronym:
  CANCER PAIN AND TREATMENT CHARACTERISTICS in GERMANY – A CROSS_SECTIONAL ONLINE PATIENT SURVEY (CANPAIN)
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study description:
  Cross-sectional electronic patient survey (conducted online in Germany) to assess relationships between the underlying cancer diagnosis (incl. TNM-stage), pain and pain-related disabilities in daily life and quality-of-life. Online patient recruitment via web site postings, flyers, and social media channels of the German Pain League, the German Pain Association, and associated networks.
• Study status:
  Finalised

Research institutions and networks

Institutions

O.Meany-MDPM

Study timelines

Date when funding contract was signed

Planned: 31/10/2016

Actual: 30/12/2016

Study start date

Planned: 01/12/2016

Actual: 01/02/2017

Data analysis start date

Planned: 01/05/2017

Actual: 01/09/2017

Date of final study report

Planned: 01/09/2017

Actual: 02/09/2019

Sources of funding

Other

More details on funding

German Pain Association, German Pain League, Institute of Neurological Sciences

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable